Example: Heart Attack

Search clinical trials for: Diethylcarbamazine

Total 22 results

    • NCT01593722
      Completed
      Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
      Conditions: Loiasis
    • NCT02845713
      Completed
      Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
      Conditions: Wuchereria Bancrofti Infection
    • NCT00511004
      Completed
      Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
      Conditions: Lymphatic Filariasis
    • NCT00295698
      Completed
      Interaction Between HIV and Lymphatic Filariasis
      Conditions: HIV Infection; Lymphatic Filariasis
    • NCT01111305
      Completed
      Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
      Conditions: Loiasis
    • NCT04410406
      Enrolling by invitation
      Moxidectin for LF, Cote d'Ivoire (DOLF)
      Conditions: Lymphatic Filariasis
    • NCT03676140
      Completed
      Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
      Conditions: Trachoma; Yaws; Lymphatic Filariases; Scabies; Strongyloidiasis
    • NCT02974049
      Completed
      Lymphatic Filariasis (LF) in Ivory Coast
      Conditions: Lymphatic Filariasis
    • NCT02005653
      Completed
      Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection
      Conditions: Filarial; Infestation
    • NCT03664063
      Completed
      PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )
      Conditions: Lymphatic Filariasis; Yaws; Trauma
    • NCT01905423
      Completed
      Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis
      Conditions: Lymphatic Filariasis; Soil Transmitted Helminth Infections
    • NCT01975441
      Completed
      Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
      Conditions: Lymphatic Filariasis
    • NCT02899936
      Completed
      Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis
      Conditions: Lymphatic Filariasis
    • NCT03177993
      Completed
      Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji
      Conditions: Lymphatic Filariases; Scabies; Impetigo; Soil Transmitted Helminths
    • NCT03352206
      Completed
      Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis
      Conditions: Lymphatic Filariases
    • NCT04188301
      Enrolling by invitation
      Safety and Efficacy of IDA for Onchocerciasis
      Conditions: Onchocerciasis
    • NCT03268252
      Completed
      Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG
      Conditions: Lymphatic Filariasis
    • NCT04035174
      Not yet recruiting
      Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
      Conditions: Onchocerciasis; Loiasis; Diagnoses Disease; Neglected Diseases
    • NCT00375583
      Completed
      Effect of Albendazole Dose on Clearance of Filarial Worms
      Conditions: Lymphatic Filariasis; Wuchereria Bancrofti Infection
    • NCT02644525
      Active, not recruiting
      Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa
      Conditions: Loaisis
    • NCT00344279
      Completed
      Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis
      Conditions: Filarial Infection; HIV Infections
    • NCT00342576
      Completed
      Host Response to Infection and Treatment in Lymphatic Filarial Disease in India
      Conditions: Lymphatic Filarial Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations